Cargando…
The Gut Microbial Metabolite Trimethylamine-N-Oxide Is Present in Human Cerebrospinal Fluid
Trimethylamine-N-oxide (TMAO) is a small organic molecule, derived from the intestinal and hepatic metabolism of dietary choline and carnitine. Although the involvement of TMAO in the framework of many chronic diseases has been recently described, no evidence on its putative role in the central nerv...
Autores principales: | , , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2017
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5691670/ https://www.ncbi.nlm.nih.gov/pubmed/28937600 http://dx.doi.org/10.3390/nu9101053 |
_version_ | 1783279835433402368 |
---|---|
author | Rio, Daniele Del Zimetti, Francesca Caffarra, Paolo Tassotti, Michele Bernini, Franco Brighenti, Furio Zini, Andrea Zanotti, Ilaria |
author_facet | Rio, Daniele Del Zimetti, Francesca Caffarra, Paolo Tassotti, Michele Bernini, Franco Brighenti, Furio Zini, Andrea Zanotti, Ilaria |
author_sort | Rio, Daniele Del |
collection | PubMed |
description | Trimethylamine-N-oxide (TMAO) is a small organic molecule, derived from the intestinal and hepatic metabolism of dietary choline and carnitine. Although the involvement of TMAO in the framework of many chronic diseases has been recently described, no evidence on its putative role in the central nervous system has been provided. The aim of this study was to evaluate whether TMAO is present at detectable levels in human cerebrospinal fluid (CSF). CSF was collected for diagnostic purposes from 58 subjects by lumbar puncture and TMAO was quantified by using liquid chromatography coupled with multiple-reaction monitoring mass spectrometry. The molecule was detected in all samples, at concentrations ranging between 0.11 and 6.43 µmol/L. Further analysis on CSF revealed that a total of 22 subjects were affected by Alzheimer’s disease (AD), 16 were affected by non-AD related dementia, and 20 were affected by other neurological disorders. However, the stratification of TMAO levels according to the neurological diagnoses revealed no differences among the three groups. In conclusion, we provide the first evidence that TMAO can be assessed in human CSF, but the actual impact of this dietary metabolite in the patho-physiolgy of the central nervous system requires further study. |
format | Online Article Text |
id | pubmed-5691670 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2017 |
publisher | MDPI |
record_format | MEDLINE/PubMed |
spelling | pubmed-56916702017-11-22 The Gut Microbial Metabolite Trimethylamine-N-Oxide Is Present in Human Cerebrospinal Fluid Rio, Daniele Del Zimetti, Francesca Caffarra, Paolo Tassotti, Michele Bernini, Franco Brighenti, Furio Zini, Andrea Zanotti, Ilaria Nutrients Communication Trimethylamine-N-oxide (TMAO) is a small organic molecule, derived from the intestinal and hepatic metabolism of dietary choline and carnitine. Although the involvement of TMAO in the framework of many chronic diseases has been recently described, no evidence on its putative role in the central nervous system has been provided. The aim of this study was to evaluate whether TMAO is present at detectable levels in human cerebrospinal fluid (CSF). CSF was collected for diagnostic purposes from 58 subjects by lumbar puncture and TMAO was quantified by using liquid chromatography coupled with multiple-reaction monitoring mass spectrometry. The molecule was detected in all samples, at concentrations ranging between 0.11 and 6.43 µmol/L. Further analysis on CSF revealed that a total of 22 subjects were affected by Alzheimer’s disease (AD), 16 were affected by non-AD related dementia, and 20 were affected by other neurological disorders. However, the stratification of TMAO levels according to the neurological diagnoses revealed no differences among the three groups. In conclusion, we provide the first evidence that TMAO can be assessed in human CSF, but the actual impact of this dietary metabolite in the patho-physiolgy of the central nervous system requires further study. MDPI 2017-09-22 /pmc/articles/PMC5691670/ /pubmed/28937600 http://dx.doi.org/10.3390/nu9101053 Text en © 2017 by the authors. Licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license (http://creativecommons.org/licenses/by/4.0/). |
spellingShingle | Communication Rio, Daniele Del Zimetti, Francesca Caffarra, Paolo Tassotti, Michele Bernini, Franco Brighenti, Furio Zini, Andrea Zanotti, Ilaria The Gut Microbial Metabolite Trimethylamine-N-Oxide Is Present in Human Cerebrospinal Fluid |
title | The Gut Microbial Metabolite Trimethylamine-N-Oxide Is Present in Human Cerebrospinal Fluid |
title_full | The Gut Microbial Metabolite Trimethylamine-N-Oxide Is Present in Human Cerebrospinal Fluid |
title_fullStr | The Gut Microbial Metabolite Trimethylamine-N-Oxide Is Present in Human Cerebrospinal Fluid |
title_full_unstemmed | The Gut Microbial Metabolite Trimethylamine-N-Oxide Is Present in Human Cerebrospinal Fluid |
title_short | The Gut Microbial Metabolite Trimethylamine-N-Oxide Is Present in Human Cerebrospinal Fluid |
title_sort | gut microbial metabolite trimethylamine-n-oxide is present in human cerebrospinal fluid |
topic | Communication |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5691670/ https://www.ncbi.nlm.nih.gov/pubmed/28937600 http://dx.doi.org/10.3390/nu9101053 |
work_keys_str_mv | AT riodanieledel thegutmicrobialmetabolitetrimethylaminenoxideispresentinhumancerebrospinalfluid AT zimettifrancesca thegutmicrobialmetabolitetrimethylaminenoxideispresentinhumancerebrospinalfluid AT caffarrapaolo thegutmicrobialmetabolitetrimethylaminenoxideispresentinhumancerebrospinalfluid AT tassottimichele thegutmicrobialmetabolitetrimethylaminenoxideispresentinhumancerebrospinalfluid AT berninifranco thegutmicrobialmetabolitetrimethylaminenoxideispresentinhumancerebrospinalfluid AT brighentifurio thegutmicrobialmetabolitetrimethylaminenoxideispresentinhumancerebrospinalfluid AT ziniandrea thegutmicrobialmetabolitetrimethylaminenoxideispresentinhumancerebrospinalfluid AT zanottiilaria thegutmicrobialmetabolitetrimethylaminenoxideispresentinhumancerebrospinalfluid AT riodanieledel gutmicrobialmetabolitetrimethylaminenoxideispresentinhumancerebrospinalfluid AT zimettifrancesca gutmicrobialmetabolitetrimethylaminenoxideispresentinhumancerebrospinalfluid AT caffarrapaolo gutmicrobialmetabolitetrimethylaminenoxideispresentinhumancerebrospinalfluid AT tassottimichele gutmicrobialmetabolitetrimethylaminenoxideispresentinhumancerebrospinalfluid AT berninifranco gutmicrobialmetabolitetrimethylaminenoxideispresentinhumancerebrospinalfluid AT brighentifurio gutmicrobialmetabolitetrimethylaminenoxideispresentinhumancerebrospinalfluid AT ziniandrea gutmicrobialmetabolitetrimethylaminenoxideispresentinhumancerebrospinalfluid AT zanottiilaria gutmicrobialmetabolitetrimethylaminenoxideispresentinhumancerebrospinalfluid |